Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Clinical trial NCT00480064 · COMPLETED

Trial details

NCT number: NCT00480064
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 1995-07-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.